Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-20 Sale |
2025-03-21 6:38 pm |
Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer |
7,935 | $31.06 | $246,425 | 96,720 (Direct) |
View |
| 2025-01-21 Sale |
2025-01-23 8:15 pm |
Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer |
3,287 | $28.59 | $93,985 | 104,655 (Direct) |
View |
| 2024-12-18 Sale |
2024-12-19 6:16 pm |
Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer |
11,151 | $32.66 | $364,192 | 82,942 (Direct) |
View |
| 2024-11-06 Sale |
2024-11-08 4:50 pm |
Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer |
106,319 | $45.56 | $4,843,979 | 154,218 (Direct) |
View |
| 2024-09-23 Sale |
2024-09-23 8:59 pm |
Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer |
11,510 | $44 | $506,440 | 121,355 (Direct) |
View |
| 2024-06-18 Sale |
2024-06-20 6:48 pm |
Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer |
11,228 | $39.13 | $439,345 | 82,865 (Direct) |
View |
| 2024-06-12 Sale |
2024-06-14 7:07 pm |
Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer |
104,245 | $35.72 | $3,723,141 | 109,275 (Direct) |
View |
| 2024-05-14 Sale |
2024-05-16 6:25 pm |
Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer |
75,000 | $28.28 | $2,121,045 | 213,520 (Direct) |
View |
| 2024-03-13 Sale |
2024-03-15 4:12 pm |
Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer |
40,000 | $24.52 | $980,760 | 288,520 (Direct) |
View |
| 2024-01-22 Sale |
2024-01-23 3:11 pm |
Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer |
1,616 | $10.13 | $16,370 | 122,884 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-06 Option Award |
2025-01-08 8:26 pm |
N/A 2035-01-05 |
Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer |
75,000 | $0 | 157,942 (Direct) |
View |
| 2024-11-06 Exercise |
2024-11-08 4:50 pm |
N/A N/A |
Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer |
13,875 | $6.57 | 154,218 (Direct) |
View |
| 2024-11-06 Exercise |
2024-11-08 4:50 pm |
N/A 2030-05-14 |
Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer |
79,057 | $0 | 154,218 (Direct) |
View |
| 2024-11-06 Exercise |
2024-11-08 4:50 pm |
N/A N/A |
Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer |
65,182 | $8.82 | 154,218 (Direct) |
View |
| 2024-09-19 Option Award |
2024-09-23 8:59 pm |
N/A N/A |
Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer |
25,000 | $0 | 121,355 (Direct) |
View |
| 2024-06-26 Option Award |
2024-06-28 07:45 am |
N/A 2034-06-25 |
Verve Therapeutics Inc. | VERV | MacLean Michael F Director |
136,139 | $0 | 136,139 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-20 6:48 pm |
N/A N/A |
Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer |
25,000 | $0 | 82,865 (Direct) |
View |
| 2024-06-12 Exercise |
2024-06-14 7:07 pm |
N/A 2030-05-14 |
Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer |
104,245 | $0 | 109,275 (Direct) |
View |
| 2024-06-12 Exercise |
2024-06-14 7:07 pm |
N/A N/A |
Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer |
104,245 | $8.82 | 109,275 (Direct) |
View |
| 2024-05-14 Exercise |
2024-05-16 6:25 pm |
N/A 2030-05-14 |
Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer |
75,000 | $0 | 213,520 (Direct) |
View |
| 2024-05-14 Exercise |
2024-05-16 6:25 pm |
N/A N/A |
Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer |
75,000 | $8.82 | 213,520 (Direct) |
View |
| 2024-03-13 Exercise |
2024-03-15 4:12 pm |
N/A 2030-05-14 |
Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer |
40,000 | $0 | 288,520 (Direct) |
View |
| 2024-03-13 Exercise |
2024-03-15 4:12 pm |
N/A N/A |
Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer |
40,000 | $8.82 | 288,520 (Direct) |
View |
| 2024-01-20 Option Award |
2024-01-23 3:11 pm |
N/A 2034-01-19 |
Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer |
128,500 | $0 | 122,884 (Direct) |
View |
| 2023-09-11 Option Award |
2023-09-12 7:33 pm |
N/A 2033-09-10 |
Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer |
74,000 | $0 | 74,000 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 5:00 pm |
N/A 2033-06-14 |
Verve Therapeutics Inc. | VERV | MacLean Michael F Director |
26,642 | $0 | 26,642 (Direct) |
View |
| 2023-02-14 Option Award |
2023-02-16 5:00 pm |
N/A 2033-02-13 |
Verve Therapeutics Inc. | VERV | MacLean Michael F Director |
7,000 | $0 | 7,000 (Direct) |
View |
| 2023-01-20 Option Award |
2023-01-24 9:06 pm |
N/A 2033-01-19 |
Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer |
166,500 | $0 | 169,852 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 5:00 pm |
N/A 2032-06-08 |
Verve Therapeutics Inc. | VERV | MacLean Michael F Director |
15,500 | $0 | 15,500 (Direct) |
View |
| 2022-01-21 Option Award |
2022-03-15 9:18 pm |
N/A 2032-01-20 |
Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer |
131,250 | $0 | 131,250 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-21 6:21 pm |
N/A 2031-06-16 |
Verve Therapeutics Inc. | VERV | MacLean Michael F Director |
47,664 | $0 | 47,664 (Direct) |
View |
| 2021-02-02 Option Award |
2021-02-04 5:06 pm |
N/A 2031-02-01 |
Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer |
92,000 | $0 | 92,000 (Direct) |
View |
Ownership |
2020-06-11 8:24 pm |
N/A 2030-05-14 |
Avidity Biosciences Inc. | RNA | MacLean Michael F Chief Financial Officer |
0 | $0 | 284,427 (Direct) |
View |